Cell-Based Assays Global Market - Forecast to 2025

Publishing Date : May, 2019
Report Code : HCBT0106
Price:
Single license $4,950
Site license $6,750
Global license $9,000


Cell-based assays refer to use of live cells in experiments, to analyze or understand various accepts of response by organism against an external therapeutic or toxic agent. The demand for cost-effective and relevant research tool in drug discovery, development and manufacturing, toxicity testing, ecotoxicology, biosafety and biocompatibility of cosmetics and chemicals is increasing interest in cell-based assays. The rise in research and the approvals of biologics and biosimilars are increasing utilization of cell-based assay as a tool for ensuring safety and potency of the product. The factors driving the market are rising use of the cell-based assay in drug discovery and development, increasing focus on biologics, technological advancements favoring the adoption of cell-based assays, the growing availability of funds for research. Whereas, factors such as lack of skilled professionals, ethical concerns over the use of raw materials from animal sources, high cost of instruments, lack of standardization, consistency and reproducibility issues are restraining the market growth.

According to IQ4I analysis, the Cell-based assays global market is is expected to grow at a CAGR of 8.0% to reach 20,053.4 million by 2025. Cell-based assays or bioassays are often an integral part of drug development in the pharma and biotech industry, which are a key component of preclinical, clinical and drug manufacturing processes. Other areas of application include, basic research, diagnostics and medical device testing, agro product and environmental testing, cosmetic testing, food and beverages testing and chemical and material testing. The Cell-based assays global market is segmented based on the products, applications, and geography. The Cell-based assays market by Products is segmented into Consumables, Instruments, and Software & Services. Among which, Consumables market commanded the largest share in 2018 growing at high single digit CAGR from 2018 to 2025.

The consumables market is further sub-segmented into assay kits, cells, microplates, reagents and others, among which reagents commanded the largest market share and is expected to grow at high CAGR from 2018 to 2025.  The assay kits are further classified based on research needs into reporter gene assay, second messenger, cell-growth assay, cell death assay, motility assays and others. Among which reporter gene assay commanded the largest revenue in 2018 and it is expected to grow at a strong CAGR, where, the increasing use of these assays in study of gene regulation, diagnostics, cell dynamics and development are factors driving the market. The cells market is sub-segmented based on source into primary cells, cell lines and stem cells, where, cell lines commanded the largest revenue in 2018 and the market is expected to grow at double digit CAGR from 2018 to 2025. The demand for cell lines in research because of the advantages such as, cost-effectiveness, ease of use, unlimited supply and bypassing of ethical concerns associated with the use of products of animal origin and human tissue are driving its growth. The emerging trend of a large number of service providers offering ready to use cell-based assay kits along with custom assay, cells and reagent development capabilities for research institutes, pharma, and biotech clients to carry out clinical and non-clinical development of pharmaceuticals, research activities, product testing to comply with regulatory requirements.

Microplate readers, liquid handling devices, flow cytometers, automated cell counters, microfluidic chips and cell microarrays, high throughput screening, high content screening, microscopes, and other instruments constitute the cell-based assays instrument market. Among which, microplate readers commanded the largest revenue in 2018, the market is expected to grow at a mid single digit CAGR from 2018 to 2025. With the advancements in label-free imaging and phenotypic screening methods in research, the microscopes market is expected to grow at a mid single digit CAGR from 2018 to 2025.

The cell-based assays geographical market consists of North America, Europe, Asia-Pacific and RoW, where North America dominates the market due to the presence of a large number of pharma-biotech companies, and investments for research from both public and private players. Asia-Pacific region is expected to show high single digit CAGR growth from 2018 to 2025, due to the presence of a large number of CROs and the emergence of this region as the manufacturing hub for biologics drugs.

Some of the key players in Cell-based assays global market are Danaher  Corp. (U.S.), ThermoFisher Scientific  (U.S.), Merck KGaA (Germany), Becton, Dickinson and Company (U.S.), Perkin Elmer, Inc. (U.S.), Lonza Group (Switzerland), Corning, Inc. (U.S.), Tecan Group (Switzerland), Bio-Rad Laboratories, Inc. (U.S.), Biotek Instruments (U.S.), Promega Corporation (U.S.) and GE Healthcare (U.S.).

The report provides an in-depth market analysis of the above-mentioned segments across the following regions:

  • North America
  • Europe
  • Asia-Pacific 
  • Rest of the World (RoW)
  • 1     EXECUTIVE SUMMARY
  • 2     INTRODUCTION
    • 2.1     KEY TAKEAWAYS
    • 2.2     SCOPE OF THE REPORT
    • 2.3     REPORT DESCRIPTION
    • 2.4     MARKETS COVERED
    • 2.5     STAKEHOLDERS
    • 2.6     RESEARCH METHODOLOGY
      • 2.6.1     MARKET CRACKDOWN AND DATA TRIANGULATION
      • 2.6.2     SECONDARY SOURCES
      • 2.6.3     KEY DATA POINTS FROM SECONDARY SOURCES
      • 2.6.4     PRIMARY SOURCES
      • 2.6.5     KEY DATA POINTS FROM PRIMARY SOURCES
      • 2.6.6     ASSUMPTIONS
  • 3     MARKET ANALYSIS
    • 3.1     INTRODUCTION
    • 3.2     MARKET SEGMENTATION
    • 3.3     FACTORS INFLUENCING MARKET
      • 3.3.1     DRIVERS AND OPPORTUNITIES
        • 3.3.1.1     RISING USE OF CELL-BASED ASSAYS IN DRUG DISCOVERY AND DEVELOPMENT
        • 3.3.1.2     INCREASING FOCUS ON BIOLOGICS
        • 3.3.1.3     TECHNOLOGICAL ADVANCEMENTS FAVORING THE ADOPTION OF CELL-BASED ASSAYS
        • 3.3.1.4     THE GROWING AVAILABILITY OF FUNDS FOR RESEARCH
      • 3.3.2     RESTRAINTS AND THREATS
        • 3.3.2.1     MAINTAINING CONSISTENCY, REPRODUCIBILITY OF ASSAYS AND LACK OF STANDARDIZATION
        • 3.3.2.2     LACK OF SKILLED PROFESSIONALS
        • 3.3.2.3     THE HIGH COST OF INSTRUMENTS AND SPECIAL RESEARCH MATERIALS
        • 3.3.2.4     ETHICAL CONCERN OVER THE USE OF RAW MATERIALS FROM ANIMAL SOURCES
    • 3.4     PORTER’S FIVE FORCE ANALYSIS
      • 3.4.1     THREAT OF NEW ENTRANTS
      • 3.4.2     THREAT OF SUBSTITUTES
      • 3.4.3     RIVALRY AMONG EXISTING COMPETITORS
      • 3.4.4     BARGAINING POWER OF SUPPLIERS
      • 3.4.5     BARGAINING POWER OF BUYERS
    • 3.5     TECHNOLOGY ADVANCEMENTS
      • 3.5.1     PREDICTIVE TOXICOLOGY
      • 3.5.2     3D BIO-PRINTING
      • 3.5.3     GENE EDITING TOOLS IN DRUG DEVELOPMENT
      • 3.5.4     VIRTUAL SCREENING, ARTIFICIAL INTELLIGENCE/MACHINE LEARNING IN DRUG DISCOVERY
    • 3.6     REGULATORY AFFAIRS
      • 3.6.1     UNITED STATES
      • 3.6.2     EUROPE
      • 3.6.3     JAPAN
      • 3.6.4     ISO STANDARDS
      • 3.6.5     OECD GUIDELINES FOR TESTING CHEMICALS
    • 3.7     DEALS
    • 3.8     MARKET SHARE ANALYSIS
      • 3.8.1     MARKET SHARE ANALYSIS: CELL-BASED ASSAYS MAJOR PLAYERS
    • 3.9     COST OF DEVICES
  • 4     CELL-BASED ASSAY GLOBAL MARKET, BY PRODUCTS
    • 4.1     INTRODUCTION
    • 4.2     CONSUMABLES
      • 4.2.1     ASSAY KITS
        • 4.2.1.1     REPORTER GENE ASSAY
        • 4.2.1.2     SECOND MESSENGER ASSAY
        • 4.2.1.3     CELL GROWTH ASSAY
        • 4.2.1.4     CELL DEATH ASSAY/CYTOTOXIC ASSAY
        • 4.2.1.5     CELL MOTILITY ASSAYS
        • 4.2.1.6     OTHERS
      • 4.2.2     CELLS
        • 4.2.2.1     CELL LINES
        • 4.2.2.2     PRIMARY CELLS
        • 4.2.2.3     STEM CELLS
      • 4.2.3     MICROPLATES
      • 4.2.4     REAGENTS
      • 4.2.5     OTHERS
    • 4.3     INSTRUMENTS
      • 4.3.1     MICROPLATE READERS
      • 4.3.2     LIQUID HANDLING SYSTEMS
      • 4.3.3     FLOWCYTOMETER
      • 4.3.4     AUTOMATED CELL COUNTERS
      • 4.3.5     MICROFLUIDIC CHIPS & CELL MICROARRAY
      • 4.3.6     HIGH THROUGHPUT SCREENING
      • 4.3.7     HIGH CONTENT SCREENING
      • 4.3.8     MICROSCOPES
      • 4.3.9     OTHERS
    • 4.4     SOFTWARE AND SERVICES
  • 5     CELL-BASED ASSAY GLOBAL MARKET, BY APPLICATIONS
    • 5.1     INTRODUCTION
    • 5.2     PHARMA AND BIOTECH
      • 5.2.1     DRUG DISCOVERY
      • 5.2.2     DRUG DEVELOPMENT
      • 5.2.3     DRUG MANUFACTURING
    • 5.3     BASIC RESEARCH
    • 5.4     DIAGNOSTICS AND MEDICAL DEVICES
    • 5.5     AGRO AND ENVIRONMENTAL TESTING
    • 5.6     COSMETICS TESTING
    • 5.7     FOOD AND BEVERAGES
    • 5.8     CHEMICALS AND MATERIALS
    • 5.9     OTHERS
  • 6     REGIONAL ANALYSIS
    • 6.1     INTRODUCTION
    • 6.2     NORTH AMERICA
      • 6.2.1     THE U.S.
      • 6.2.2     REST OF NORTH AMERICA
    • 6.3     EUROPE
      • 6.3.1     GERMANY
      • 6.3.2     U.K.
      • 6.3.3     FRANCE
      • 6.3.4     REST OF EUROPE
    • 6.4     APAC
      • 6.4.1     CHINA
      • 6.4.2     JAPAN
      • 6.4.3     INDIA
      • 6.4.4     REST OF APAC
    • 6.5     ROW
      • 6.5.1     BRAZIL
      • 6.5.2     REST OF LATAM
      • 6.5.3     MIDDLE EAST & OTHERS
  • 7     COMPETITIVE LANDSCAPE
    • 7.1     INTRODUCTION
    • 7.2     NEW PRODUCT LAUNCH
    • 7.3     AGREEMENTS & COLLABORATIONS
    • 7.4     ACQUISITIONS
    • 7.5     OTHERS
  • 8     MAJOR PLAYER PROFILES
    • 8.1     BECTON, DICKINSON AND COMPANY
      • 8.1.1     OVERVIEW
      • 8.1.2     FINANCIALS
      • 8.1.3     PRODUCT PORTFOLIO
      • 8.1.4     KEY DEVELOPMENTS
      • 8.1.5     BUSINESS STRATEGY
      • 8.1.6     SWOT ANALYSIS
    • 8.2     BIO-RAD LABORATORIES
      • 8.2.1     OVERVIEW
      • 8.2.2     FINANCIALS
      • 8.2.3     PRODUCT PORTFOLIO
      • 8.2.4     KEY DEVELOPMENTS
      • 8.2.5     BUSINESS STRATEGY
      • 8.2.6     SWOT ANALYSIS
    • 8.3     BIOTEK INSTRUMENTS, INC
      • 8.3.1     OVERVIEW
      • 8.3.2     FINANCIALS
      • 8.3.3     PRODUCT PORTFOLIO
      • 8.3.4     KEY DEVELOPMENTS
      • 8.3.5     BUSINESS STRATEGY
      • 8.3.6     SWOT ANALYSIS
    • 8.4     CORNING INC.
      • 8.4.1     OVERVIEWS
      • 8.4.2     FINANCIALS
      • 8.4.3     PRODUCT PORTFOLIO
      • 8.4.4     KEY DEVELOPMENTS
      • 8.4.5     BUSINESS STRATEGY
      • 8.4.6     SWOT ANALYSIS
    • 8.5     DANAHER CORPORATION
      • 8.5.1     OVERVIEW
      • 8.5.2     FINANCIALS
      • 8.5.3     PRODUCT PORTFOLIO
      • 8.5.4     KEY DEVELOPMENTS
      • 8.5.5     BUSINESS STRATEGY
      • 8.5.6     SWOT ANALYSIS
    • 8.6     LONZA GROUP LTD
      • 8.6.1     OVERVIEW
      • 8.6.2     FINANCIALS
      • 8.6.3     PRODUCT PORTFOLIO
      • 8.6.4     KEY DEVELOPMENTS
      • 8.6.5     BUSINESS STRATEGY
      • 8.6.6     SWOT ANALYSIS
    • 8.7     MERCK KGAA
      • 8.7.1     OVERVIEW
      • 8.7.2     FINANCIALS
      • 8.7.3     PRODUCT PORTFOLIO
      • 8.7.4     KEY DEVELOPMENTS
      • 8.7.5     BUSINESS STRATEGY
      • 8.7.6     SWOT ANALYSIS
    • 8.8     PERKINELMER, INC
      • 8.8.1     OVERVIEW
      • 8.8.2     FINANCIALS
      • 8.8.3     PRODUCT PORTFOLIO
      • 8.8.4     KEY DEVELOPMENTS
      • 8.8.5     BUSINESS STRATEGY
      • 8.8.6     SWOT ANALYSIS
    • 8.9     TECAN TRADING AG
      • 8.9.1     OVERVIEW
      • 8.9.2     FINANCIALS
      • 8.9.3     PRODUCT PORTFOLIO
      • 8.9.4     KEY DEVELOPMENTS
      • 8.9.5     BUSINESS STRATEGY
      • 8.9.6     SWOT ANALYSIS
    • 8.1     THERMO FISHER SCIENTIFIC
      • 8.10.1     OVERVIEW
      • 8.10.2     FINANCIALS
      • 8.10.3     PRODUCT PORTFOLIO
      • 8.10.4     KEY DEVELOPMENTS
      • 8.10.5     BUSINESS STRATEGY
      • 8.10.6     SWOT ANALYSIS

      LIST OF TABLES

      • TABLE 1     CELL-BASED ASSAY GLOBAL MARKET REVENUE, BY REGION (2017-2025) ($MN)
      • TABLE 2     CELL-BASED ASSAYS GLOBAL MARKET REVENUE, BY PRODUCTS, (2017-2025) ($MN)
      • TABLE 3     CONSUMABLES GLOBAL MARKET REVENUE, BY PRODUCTS, (2017-2025) ($MN)
      • TABLE 4     CONSUMABLES GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 5     ASSAY KITS GLOBAL MARKET REVENUE, BY RESEARCH NEED, (2017-2025) ($MN)
      • TABLE 6     ASSAY KITS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 7     REPORTER GENE ASSAY GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 8     SECOND MESSENGER ASSAY GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 9     CELL GROWTH ASSAY GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)112
      • TABLE 10     CELL DEATH ASSAY/CYTOTOXICITY ASSAY GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 11     CELL MOTILITY ASSAY GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 12     OTHERS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 13     CELLS GLOBAL MARKET REVENUE, BY SOURCE, (2017-2025) ($MN)
      • TABLE 14     CELLS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 15     CELL LINES GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 16     PRIMARY CELLS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 17     STEM CELLS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)141
      • TABLE 18     MICROPLATES GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 19     REAGENTS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 20     OTHERS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 21     INSTRUMENTS GLOBAL MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 22     INSTRUMENTS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 23     MICROPLATE READERS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 24     LIQUID HANDLING SYSTEMS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 25     FLOW CYTOMETER SYSTEMS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 26     AUTOMATED CELL COUNTERS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 27     MICROFULIDIC CHIPS & CELL MICROARRAYS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 28     HIGH THROUGHPUT SCREENING GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 29     HIGH CONTENT SCREENING GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 30     MICROSCOPES GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 31     OTHERS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 32     SOFTWARE AND SERVICE GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 33     CELL-BASED ASSAY GLOBAL MARKET REVENUE, BY APPLICATION, (2017-2025) ($MN)
      • TABLE 34     PHARMA AND BIOTECH APPLICATION GLOBAL MARKET REVENUE, BY REGION,(2017-2025) ($MN)
      • TABLE 35     PHARMA AND BIOTECH APPLICATION GLOBAL MARKET REVENUE, BY PURPOSE, (2017-2025) ($MN)
      • TABLE 36     DRUG DISCOVERY APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 37     COMPANY COMPARISON MATRIX BY DRUG DISCOVERY SERVICES CAPABILITIES
      • TABLE 38     DRUG DEVELOPMENT GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 39     COMPANY COMPARISON MATRIX BY DRUG DEVELOPMENT SERVICES CAPABILITIES
      • TABLE 40     DRUG MANUFACTURING GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 41     COMPANY COMPARISON MATRIX BY DRUG DEVELOPMENT SERVICES CAPABILITIES
      • TABLE 42     BASIC RESEARCH GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 43     DIAGNOSTIC AND MEDICAL DEVICES TESTING GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 44     AGRO AND ENVIRONMENTAL TESTING APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 45     COSMETICS TESTING APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 46     FOOD AND BEVERAGE APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 47     CHEMICALS AND MATERIALS APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 48     OTHERS APPLICATION GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 49     CELL-BASED ASSAYS GLOBAL MARKET REVENUE, BY REGION, (2017-2025) ($MN)
      • TABLE 50     NORTH AMERICA CELL-BASED ASSAYS MARKET REVENUE, BY PRODUCT, (2017-2025) ($MN)
      • TABLE 51     NORTH AMERICA CONSUMABLES MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
      • TABLE 52     NORTH AMERICA CELLS MARKET REVENUE, BY SOURCE, (2017-2025) ($MN)
      • TABLE 53     NORTH AMERICA ASSAY KITS MARKET REVENUE, BY RESEARCH NEED, (2017-2025) ($MN)
      • TABLE 54     NORTH AMERICA CELL-BASED ASSAYS INSTRUMENT MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 55     NORTH AMERICA CELL-BASED ASSAYS MARKET REVENUE, BY APPLICATION, (2017-2025) ($MN)
      • TABLE 56     NORTH AMERICA PHARMA AND BIOTECH MARKET REVENUE, BY PURPOSE, (2017-2025) ($MN)
      • TABLE 57     NORTH AMERICA CELL-BASED ASSAYS MARKET REVENUE, BY COUNTRY, (2017-2025) ($MN)
      • TABLE 58     EUROPE CELL-BASED ASSAYS MARKET REVENUE, BY PRODUCT, (2017-2025) ($MN)
      • TABLE 59     EUROPE CONSUMABLES MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
      • TABLE 60     EUROPE CELLS MARKET REVENUE, BY SOURCE, (2017-2025) ($MN)
      • TABLE 61     EUROPE ASSAY KITS MARKET REVENUE, BY RESEARCH NEED, (2017-2025) ($MN)
      • TABLE 62     EUROPE CELL-BASED ASSAYS INSTRUMENTS MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 63     EUROPE CELL-BASED ASSAYS MARKET REVENUE, BY APPLICATION, (2017-2025) ($MN)
      • TABLE 64     EUROPE PHARMA AND BIOTECH MARKET REVENUE, BY PURPOSE, (2017-2025) ($MN)
      • TABLE 65     EUROPE CELL-BASED ASSAY REGIONAL MARKET REVENUE, BY COUNTRY, (2017-2025) ($MN)
      • TABLE 66     APAC CELL-BASED ASSAYS MARKET REVENUE, BY PRODUCT, (2018-2025) ($MN)
      • TABLE 67     APAC CONSUMABLES MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
      • TABLE 68     APAC ASSAY KITS MARKET REVENUE, BY RESEARCH NEED, (2017-2025) ($MN)
      • TABLE 69     APAC CELLS MARKET REVENUE, BY SOURCE, (2017-2025) ($MN)
      • TABLE 70     APAC CELL-BASED ASSAYS INSTRUMENTS MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 71     APAC CELL-BASED ASSAYS MARKET REVENUE, BY APPLICATION, (2017-2025) ($MN)
      • TABLE 72     APAC PHARMA AND BIOTECH MARKET REVENUE, BY PURPOSE, (2017-2025) ($MN)
      • TABLE 73     APAC CELL-BASED ASSAYS MARKET REVENUE, BY COUNTRY, (2017-2025) ($MN)
      • TABLE 74     ROW CELL-BASED ASSAYS MARKET REVENUE, BY PRODUCT, (2017-2025) ($MN)
      • TABLE 75     ROW CONSUMABLES MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
      • TABLE 76     ROW CELLS MARKET REVENUE, BY SOURCE, (2017-2025) ($MN)
      • TABLE 77     ROW ASSAY KITS MARKET REVENUE, BY RESEARCH NEED, (2017-2025) ($MN)
      • TABLE 78     ROW CELL-BASED ASSAYS INSTRUMENTS MARKET REVENUE, BY TYPE, (2017-2025) ($MN)
      • TABLE 79     ROW CELL-BASED ASSAYS MARKET REVENUE, BY APPLICATION, (2017-2025) ($MN)
      • TABLE 80     ROW PHARMA AND BIOTECH MARKET REVENUE, BY PURPOSE, (2017-2025) ($MN)
      • TABLE 81     ROW CELL-BASED ASSAYS MARKET REVENUE, BY COUNTRY, (2017-2025) ($MN)
      • TABLE 82     NEW PRODUCT LAUNCH (2017-2019)
      • TABLE 83     AGREEMENTS & COLLABORATIONS (2017-2019)
      • TABLE 84     ACQUISITIONS (2017-2019)
      • TABLE 85     BECTON, DICKINSON AND COMPANY: TOTAL REVENUE AND R&D EXPENSES (2016-2018) ($MN)
      • TABLE 86     BECTON, DICKINSON AND COMPANY: TOTAL REVENUE, BY SEGMENT, (2016-2018) ($MN)
      • TABLE 87     BECTON, DICKINSON AND COMPANY: TOTAL REVENUE, LIFE SCIENCE SEGMENT, (2016-2018) ($MN)
      • TABLE 88     BECTON, DICKINSON AND COMPANY: TOTAL REVENUE, BY REGION, (2016-2018) ($MN)
      • TABLE 89     BIO-RAD LABORATORIES REVENUE & R&D EXPENSES (2016-2018(Q3)) ($MN)
      • TABLE 90     BIO-RAD LABORATORIES: TOTAL REVENUE, BY SEGMENT, (2016-2018(Q3)) ($MN)
      • TABLE 91     BIO-RAD LABORATORIES: TOTAL REVENUE, BY REGION, (2016-2018(Q3)) ($MN)
      • TABLE 92     CORNING INC: TOTAL REVENUE AND R&D EXPENSES (2016-2018) ($MN)
      • TABLE 93     CORNING INC: TOTAL REVENUE, BY SEGMENT, (2016-2018) ($MN)
      • TABLE 94     CORNING INC.: TOTAL REVENUE, BY REGION, (2016-2018) ($MN)
      • TABLE 95     DANAHER CORPORATION: TOTAL REVENUE AND R&D EXPENSES (2016-2018(Q3)) ($MN)
      • TABLE 96     DANAHER CORPORATION: TOTAL REVENUE, BY SEGMENT, (2016-2018(Q3)) ($MN)
      • TABLE 97     DANAHER CORPORATION: TOTAL REVENUE, BY REGION, (2016-2018(Q3)) ($MN)
      • TABLE 98     LONZA GROUP LTD: TOTAL REVENUE AND R&D EXPENSES (2016-2018) ($MN)
      • TABLE 99     LONZA GROUP LTD: TOTAL REVENUE, BY SEGMENT, (2016-2018) ($MN)
      • TABLE 100     LONZA GROUP LTD: TOTAL REVENUE, BY GEOGRAPHY, (2016-2018) ($MN)
      • TABLE 101     MERCK KGAA: TOTAL REVENUE AND R&D EXPENSES (2016-2018(Q3) ($MN)
      • TABLE 102     MERCK KGAA: TOTAL REVENUE, BY SEGMENT, (2016-2018(Q3)) ($MN)
      • TABLE 103     MERCK KGAA: TOTAL REVENUE, BY REGION, (2016-2018(Q3) ($MN)
      • TABLE 104     PERKINELMER, INC: TOTAL REVENUE AND R&D EXPENSES (2016-2018(Q3)) ($MN)
      • TABLE 105     PERKINELMER, INC: TOTAL REVENUE, BY SEGMENT, (2016-2018(Q3)) ($MN)
      • TABLE 106     PERKINELMER, INC: TOTAL REVENUE, BY REGION, (2016-2018(Q3)) ($MN)
      • TABLE 107     TECAN: TOTAL REVENUE AND R&D EXPENSES (2016-2018) ($MN)
      • TABLE 108     TECAN: TOTAL REVENUE, BY SEGMENT, (2016-2018) ($MN)
      • TABLE 109     TECAN: TOTAL REVENUE, BY REGION, (2016-2018) ($MN)
      • TABLE 110     THERMO FISHER SCIENTIFIC: TOTAL REVENUE AND R&D EXPENSES (2016-2018) ($MN)
      • TABLE 111     THERMO FISHER SCIENTIFIC: TOTAL REVENUE, BY SEGMENT, (2016-2018) ($MN)

      LIST OF FIGURES

      • FIGURE 1     CELL-BASED ASSAY MARKET REVENUE & SHARE, BY GEOGRAPHY, (2018-2025) ($MN)
      • FIGURE 2     CELL-BASED ASSAY GLOBAL MARKET: RESEARCH APPROACH
      • FIGURE 3     CELL-BASED ASSAY MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
      • FIGURE 4     CELL-BASED ASSAY GLOBAL MARKET: FORECASTING MODEL
      • FIGURE 5     CELL-BASED ASSAY GLOBAL MARKET: MARKET CRACKDOWN AND DATA TRIANGULATION
      • FIGURE 6     CELL-BASED ASSAY GLOBAL MARKET: MARKET SEGMENTATION
      • FIGURE 7     MARKET DYNAMICS
      • FIGURE 8     PORTER’S FIVE FORCE ANALYSIS
      • FIGURE 9     CELL-BASED ASSAYS GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2018
      • FIGURE 10     CELL-BASED ASSAYS GLOBAL MARKET SHARE, BY PRODUCTS (2018 V’S 2025) (%)
      • FIGURE 11     CONSUMABLES GLOBAL MARKET SHARE, BY PRODUCT TYPE (2018) (%)
      • FIGURE 12     ASSAY KITS GLOBAL MARKET SHARE, BY RESEARCH NEED (2018 V/S 2025)%
      • FIGURE 13     CELLS GLOBAL MARKET SHARE, BY REGION (2018 V/S 2025) (%)
      • FIGURE 14     INSTRUMENTS GLOBAL MARKET SHARE, BY TYPE (2018 V’S 2025) (%)
      • FIGURE 15     INSTRUMENTS GLOBAL MARKET REVENUE, BY REGION (2018 V’S 2025) ($MN)
      • FIGURE 16     CELL-BASED ASSAY GLOBAL MARKET SHARE, BY APPLICATION (2018 V’S 2025) (%)
      • FIGURE 17     PHARMA AND BIOTECH GLOBAL MARKET REVENUE, BY PURPOSE (2018 V’S 2025) ($MN)
      • FIGURE 18     DRUG DISCOVERY GLOBAL MARKET REVENUE, BY REGION (2018 V’S 2025) ($MN)
      • FIGURE 19     BASIC RESEARCH GLOBAL MARKET REVENUE, BY REGION (2018 V’S 2025) ($MN)
      • FIGURE 20     AGRO AND ENVIRONMENTAL TESTING GLOBAL MARKET REVENUE, BY REGION (2018 V’S 2025) ($MN)
      • FIGURE 21     COSMETICS TESTING GLOBAL MARKET REVENUE, BY REGION (2018 V’S 2025) ($MN)
      • FIGURE 22     CELL-BASED ASSAYS GLOBAL MARKET REVENUE, BY REGION (2017-2025) ($MN), CAGR (%)
      • FIGURE 23     CELL-BASED ASSAYS GLOBAL MARKET SHARE, BY REGION AND BY COUNTRY (2018) (%)
      • FIGURE 24     NORTH AMERICA CELL-BASED ASSAY MARKET REVENUE, BY PRODUCT (2018 V/S 2025), CONSUMABLES, BY PRODUCT TYPE AND CELLS, BY SOURCE (2018) ($MN)
      • FIGURE 25     NORTH AMERICA ASSAY KITS MARKET REVENUE, BY RESEARCH NEED (2018 V/S 2025) ($MN)
      • FIGURE 26     NORTH AMERICA CELL-BASED ASSAYS INSTRUMENTS MARKET REVENUE, BY TYPE (2018 V/S 2025) ($MN)
      • FIGURE 27     NORTH AMERICA INSTRUMENT MARKET REVENUE, BY APPLICATION, PHARMA AND BIOTECH BY PURPOSE (2018) ($MN)
      • FIGURE 28     NORTH AMERICA CELL-BASED ASSAYS MARKET REVENUE, BY COUNTRY (2018 V/S 2025) ($MN)
      • FIGURE 29     U.S. CELL-BASED ASSAYS MARKET REVENUE, BY PRODUCT, CONSUMABLES, BY PRODUCT TYPE (2018 V/S 2025) ($MN)
      • FIGURE 30     U.S. CELL-BASED ASSAYS INSTRUMENTS MARKET REVENUE, BY PRODUCT TYPE (2018 V/S 2025) ($MN)
      • FIGURE 31     U.S. CELL-BASED ASSAYS MARKET REVENUE, BY APPLICATION (2018 V/S 2025) ($MN)
      • FIGURE 32     REST OF NORTH AMERICA CELL-BASED ASSAYS MARKET REVENUE, BY PRODUCT, CONSUMABLES, BY PRODUCT TYPE (2018 V/S 2025) ($MN)
      • FIGURE 33     REST OF NORTH AMERICA CELL-BASED ASSAYS INSTRUMENTS MARKET REVENUE, BY PRODUCT TYPE (2018 V/S 2025) ($MN)
      • FIGURE 34     REST OF NORTH AMERICA CELL-BASED ASSAYS MARKET REVENUE, BY APPLICATIONS (2018 V/S 2025) ($MN)
      • FIGURE 35     EUROPE CELL-BASED ASSAYS MARKET REVENUE, BY PRODUCT, (2018 V/S 2025), CONSUMABLES, BY PRODUCT TYPE AND CELLS BY SOURCE (2018) ($MN)
      • FIGURE 36     EUROPE ASSAY KITS MARKET REVENUE, BY RESEARCH NEED, (2018 V/S 2025) ($MN)
      • FIGURE 37     EUROPE CELL-BASED ASSAYS INSTRUMENTS MARKET REVENUE, BY PRODUCT TYPE, (2017-2025) ($MN)
      • FIGURE 38     EUROPE CELL-BASED ASSAYS MARKET REVENUE, BY APPLICATION, PHARMA AND BIOTECH APPLICATION, BY PURPOSE, (2018) ($MN)
      • FIGURE 39     EUROPE CELL-BASED ASSAYS SHARE, BY COUNTRY (2018 V/S 2025) ($ MN)
      • FIGURE 40     GERMANY CELL-BASED ASSAYS MARKET REVENUE, BY PRODUCT, CONSUMABLES, BY PRODUCT TYPE (2018 V/S 2025) ($MN)
      • FIGURE 41     GERMANY INSTRUMENTS MARKET REVENUE, BY PRODUCT TYPE (2018 V/S 2025) ($MN)
      • FIGURE 42     GERMANY CELL-BASED ASSAYS MARKET REVENUE, BY APPLICATION (2018 V/S 2025) ($MN)
      • FIGURE 43     U.K. CELL-BASED ASSAYS MARKET REVENUE, BY PRODUCT, CONSUMABLES, BY PRODUCT TYPE (2018 V/S 2025) ($MN)
      • FIGURE 44     U.K. INSTRUMENTS MARKET REVENUE, BY PRODUCT TYPE (2018 V/S 2015) ($MN)
      • FIGURE 45     U.K. CELL-BASED ASSAY MARKET REVENUE, BY APPLICATION (2018 V/S 2015) ($MN)
      • FIGURE 46     FRANCE CELL-BASED ASSAY MARKET REVENUE, BY PRODUCT, CONSUMABLES, BY PRODUCT TYPE (2018 V/S 2025) ($MN)
      • FIGURE 47     FRANCE INSTRUMENT MARKET REVENUE, BY PRODUCT TYPE (2018 V/S 2015) ($MN)
      • FIGURE 48     FRANCE CELL-BASED ASSAYS MARKET REVENUE, BY APPLICATION (2018 V/S 2025) ($MN)
      • FIGURE 49     REST OF EUROPE CELL-BASED ASSAYS MARKET REVENUE, BY PRODUCT, CONSUMABLES, BY PRODUCT TYPE (2018 V/S 2025) ($MN)
      • FIGURE 50     REST OF EUROPE INSTRUMENTS MARKET REVENUE, BY PRODUCT TYPE (2018 V/S 2015) ($MN),
      • FIGURE 51     REST OF EUROPE CELL-BASED ASSAYS MARKET REVENUE, BY APPLICATION (2018 V/S 2025) ($MN)
      • FIGURE 52     APAC ASSAY KIT MARKET REVENUE, BY RESEARCH NEED (2018 V/S 2025) ($MN)
      • FIGURE 53     APAC CELL-BASED ASSAYS MARKET REVENUE, BY PRODUCT (2018 V/S 2025), CONSUMABLES BY PRODUCT TYPE AND CELLS BY SOURCE (2018) ($MN)
      • FIGURE 54     APAC CELL-BASED ASSAYS INSTRUMENTS MARKET REVENUE, BY PRODUCT TYPE (2018 V/S 2025) ($MN)
      • FIGURE 55     APAC CELL-BASED ASSAYS MARKET REVENUE, BY APPLICATION, PHARMA AND BIOTECH APPLICATION, BY PURPOSE (2018) ($MN)
      • FIGURE 56     APAC CELL-BASED ASSAYS MARKET REVENUE, BY COUNTRY (2018 V/S 2025) ($MN)
      • FIGURE 57     CHINA CELL-BASED ASSAYS MARKET REVENUE, BY PRODUCT, CONSUMABLES MARKET REVENUE, BY PRODUCT TYPE (2018 V/S 2025) ($MN)
      • FIGURE 58     CHINA CELL-BASED ASSAYS INSTRUMENTS MARKET REVENUE, BY PRODUCT TYPE (2018 V/S 2025) ($MN)
      • FIGURE 59     CHINA CELL-BASED ASSAYS MARKET REVENUE, BY APPLICATION (2018 V/S 2025) ($MN)
      • FIGURE 60     JAPAN CELL-BASED ASSAYS MARKET REVENUE, BY PRODUCT, CONSUMABLES MARKET REVENUE, BY PRODUCT TYPE (2018 V/S 2025) ($MN)
      • FIGURE 61     JAPAN CELL-BASED ASSAYS INSTRUMENTS MARKET REVENUE, BY PRODUCT TYPE (2018 V/S 2025) ($MN)
      • FIGURE 62     JAPAN CELL-BASED ASSAYS MARKET REVENUE, BY APPLICATION (2018 V/S 2025) ($MN)
      • FIGURE 63     INDIA CELL-BASED ASSAYS MARKET REVENUE, BY PRODUCT, CONSUMABLES, BY PRODUCT TYPE (2018 V/S 2025) ($MN)
      • FIGURE 64     INDIA CELL-BASED ASSAYS INSTRUMENTS MARKET REVENUE, BY PRODUCT TYPE (2018 V/S 2015) ($MN)
      • FIGURE 65     INDIA CELL-BASED ASSAYS MARKET REVENUE, BY APPLICATION (2018 V/S 2015) ($MN)
      • FIGURE 66     REST OF APAC CELL-BASED ASSAYS MARKET REVENUE, BY PRODUCT, CONSUMABLES, BY PRODUCT TYPE (2018 V/S 2025) ($MN)
      • FIGURE 67     REST OF APAC CELL-BASED ASSAYS INSTRUMENTS MARKET REVENUE, PRODUCT TYPE (2018 V/S 2025) ($MN)
      • FIGURE 68     REST OF APAC CELL-BASED ASSAYS MARKET REVENUE, BY APPLICATION (2018 V/S 2025) ($MN)
      • FIGURE 69     ROW CELL-BASED ASSAYS MARKET REVENUE, BY PRODUCT (2018 V/S 2025), CONSUMABLES, BY PRODUCT TYPE AND CELLS, BY SOURCE (2018)($MN)
      • FIGURE 70     ROW ASSAY KITS MARKET REVENUE, BY RESEARCH NEED (2018 V/S 2025) ($MN)
      • FIGURE 71     ROW CELL-BASED ASSAYS INSTRUMENTS MARKET REVENUE, BY PRODUCT TYPE (2018 V/S 2015) ($MN)
      • FIGURE 72     ROW CELL-BASED ASSAY MARKET REVENUE, BY APPLICATION, PHARMA AND BIOTECH APPLICATION, BY PURPOSE (2018) ($MN)
      • FIGURE 73     ROW CELL-BASED ASSAYS MARKET REVENUE, BY COUNTRY (2018 V/S 2025) ($MN)
      • FIGURE 74     BRAZIL CELL-BASED ASSAYS MARKET REVENUE, BY PRODUCT CONSUMABLES MARKET REVENUE, BY PRODUCT TYPE (2018 V/S 2025) ($MN)
      • FIGURE 75     BRAZIL CELL-BASED ASSAYS INSTRUMENTS MARKET REVENUE, BY PRODUCT TYPE (2018 V/S 2025) ($MN)
      • FIGURE 76     BRAZIL CELL-BASED ASSAYS MARKET REVENUE, BY APPLICATION (2018 V/S 2025) ($MN)
      • FIGURE 77     REST OF LATAM CELL-BASED ASSAYS MARKET REVENUE, BY PRODUCT, CONSUMABLES MARKET REVENUE BY PRODUCT TYPE (2018 V/S 2025) ($MN)
      • FIGURE 78     REST OF LATAM CELL-BASED ASSAYS INSTRUMENTS MARKET REVENUE, BY TYPE (2018 V/S 2025) ($MN)
      • FIGURE 79     REST OF LATAM CELL-BASED ASSAYS MARKET REVENUE, BY APPLICATION (2018 V/S 2025) ($MN)
      • FIGURE 80     MIDDLE EAST AND OTHERS CELL-BASED ASSAYS MARKET REVENUE, BY PRODUCT, CONSUMABLES, BY PRODUCT TYPE (2018 V/S 2025) ($MN)
      • FIGURE 81     MIDDLE EAST AND OTHERS CELL-BASED ASSAYS INSTRUMENTS MARKET REVENUE, BY PRODUCT TYPE (2018 V/S 2015) ($MN)
      • FIGURE 82     MIDDLE EAST AND OTHERS CELL-BASED ASSAYS MARKET REVENUE, BY APPLICATION (2018 V/S 2025) ($MN)
      • FIGURE 83     KEY GROWTH STRATEGIES (2017-2019)
      • FIGURE 84     OVERVIEW: BECTON, DICKINSON AND COMPANY
      • FIGURE 85     SWOT: BECTON, DICKINSON AND COMPANY
      • FIGURE 86     OVERVIEW: BIO-RAD LABORATORIES
      • FIGURE 87     SWOT: BIO-RAD LABORATORIES
      • FIGURE 88     SWOT: BIOTEK INSTRUMENTS, INC
      • FIGURE 89     OVERVIEW: CORNING, INC
      • FIGURE 90     SWOT: CORNING, INC
      • FIGURE 91     OVERVIEW: DANAHER CORPORATION
      • FIGURE 92     SWOT: DANAHER CORPORATION
      • FIGURE 93     OVERVIEW: LONZA GROUP LTD
      • FIGURE 94     SWOT: LONZA GROUP LTD.
      • FIGURE 95     OVERVIEW: MERCK KGAA
      • FIGURE 96     SWOT: MERCK KGAA
      • FIGURE 97     OVERVIEW: PERKINELMER, INC.
      • FIGURE 98     SWOT: PERKINELMER, INC.
      • FIGURE 99     OVERVIEW: TECAN TRADING AG
      • FIGURE 100     SWOT: TECAN
      • FIGURE 101     OVERVIEW: THERMO FISHER SCIENTIFIC
      • FIGURE 102     SWOT: THERMO FISHER SCIENTIFIC

      LIST OF COMPANIES MENTIONED IN THE REPORT

      • 1     ABSORPTION SYSTEMS, LP
      • 2     ABZENA
      • 3     ACROSS BARRIERS GMBH
      • 4     ADOOQ BIOSCIENCE LLC
      • 5     ADVANCED BIOMATRIX INC
      • 6     AFFINITY BIOLOGICALS
      • 7     AGILENT TECHNOLOGIES, INC.
      • 8     AGRENVEC
      • 9     AIMPLEX BIOSCIENCES, INC.
      • 10     AKESO BIOPHARMA
      • 11     ALLCELLS
      • 12     ALBANY MOLECULAR RESEARCH INC. (AMRI) CARLYLE GROUP
      • 13     ANTAGEN PHARMACEUTICALS, INC.
      • 14     ANTHEM BIOSCIENCES
      • 15     APACOR
      • 16     APPLIED BIOLOGICAL MATERIALS (ABM) INC.
      • 17     APPLIED GENETICS LABORATORIES, INC.
      • 18     APPLIED STEMCELL
      • 19     ARBOR ASSAYS LLC
      • 20     ARP AMERICAN RESEARCH PRODUCTS, INC
      • 21     ART ROBBINS INSTRUMENTS LLC
      • 22     ASCENDANCE BIOTECHNOLOGY, INC (BIOIVT)
      • 23     ASSAY. WORKS GMBH
      • 24     ATCC
      • 25     ATTAGENE, INC.
      • 26     AURELIA BIOSCIENCE LTD.
      • 27     BECTON, DICKINSON AND COMPANY
      • 28     BIOAGILYTIX LABS
      • 29     BIOALTERNATIVES, SAS
      • 30     BIOASSAY GMBH
      • 31     BIOPTA, LTD.
      • 32     BIO-RAD LABORATORIES, INC.
      • 33     BIOSPHERIX, LTD.
      • 34     BIOTEK INSTRUMENTS, INC.
      • 35     BIOTESYS GMBH
      • 36     BIOTHEMA AB
      • 37     BIOVISION, INC
      • 38     BMG LABTECH
      • 39     BRAINTREE SCIENTIFIC, INC.
      • 40     BRAND GMBH
      • 41     BSL BIOSERVICE
      • 42     CANVAX
      • 43     CARNA BIOSCIENCES, INC.
      • 44     CELL BIOLABS, INC
      • 45     CELL GUIDANCE SYSTEMS LTD.
      • 46     CELLS-SAFE
      • 47     CELL SIGNALING TECHNOLOGY, INC.
      • 48     CELL TECHNOLOGY, INC.
      • 49     CELLSAFE BIOTECH GROUP
      • 50     CELLULAR DYNAMICS INTERNATIONAL
      • 51     CELPROGEN, INC.
      • 52     CHARLES RIVER LABORATORIES, INC
      • 53     CISBIO BIOASSAYS
      • 54     CLINACTIS PTE LTD
      • 55     CORNING, INC.
      • 56     COVANCE, INC.
      • 57     CREATIVE BIOARRAY
      • 58     CYBIO AG (ANALYTIK JENA)
      • 59     EVOTEC (CYPROTEX)
      • 60     CYTOSKELETON, INC.
      • 61     DANAHER CORPORATION
      • 62     ECM BIOSCIENCES
      • 63     EMBI TEC
      • 64     ENZO LIFE SCIENCES INC.
      • 65     EUROFINS -DISCOVERX
      • 66     EXPLICYTE
      • 67     FIRALIS S.A.
      • 68     GE HEALTHCARE
      • 69     GENLANTIS, INC.
      • 70     GVK BIOSCIENCES PRIVATE LIMITED
      • 71     HAMAMATSU
      • 72     HAMILTON COMPANY
      • 73     HUREL CORPORATION
      • 74     IBT BIOSERVICE
      • 75     ILLUMINA
      • 76     IMMUNO CHEMISTRY TECHNOLOGIES
      • 77     IN VITRO INTERNATIONAL
      • 78     INDIGO BIOSCIENCES
      • 79     INSPHERO AG
      • 80     INVIVOGEN
      • 81     IQVIA
      • 82     JRF GLOBAL
      • 83     KERAFAST, INC.
      • 84     LEINCO TECHNOLOGIES, INC.
      • 85     LIFELINE CELL TECHNOLOGY, LLC
      • 86     LKT LABORATORIES, INC.
      • 87     LOGOS BIOSYSTEMS
      • 88     LONZA GROUP AG
      • 89     MATTEK CORPORATION
      • 90     MD BIOSCIENCES, INC.
      • 91     MERCK & CO., INC.
      • 92     MERCK KGAA
      • 93     METRION BIOSCIENCE
      • 94     MICROARRAYS, INC.
      • 95     MILTENYI BIOTEC
      • 96     MIMETAS B.V
      • 97     MITEGEN LLC
      • 98     MODULINE SYSTEMS INC.
      • 99     NANO 3D BIOSCIENCES, INC
      • 100     NCARDIA
      • 101     NMS LABS
      • 102     NORTIS, INC
      • 103     ORGANOVO HOLDINGS INC.
      • 104     ORIGENE TECHNOLOGIES
      • 105     OXFORD EXPRESSION TECHNOLOGIES LTD
      • 106     OZ BIOSCIENCE
      • 107     PACIFIC BIOLABS
      • 108     PAREXEL INTERNATIONAL CORPORATION
      • 109     PBL ASSAY SCIENCE
      • 110     PERKIN ELMER, INC.
      • 111     PHENOVISTA BIOSCIENCES
      • 112     PLURISELECT GMBH
      • 113     PORSOLT
      • 114     PREDITOX
      • 115     PROBIOGEN
      • 116     PROFOLDIN
      • 117     PROIMMUNE LTD
      • 118     PROMEGA CORPORATION
      • 119     PROMOCELL
      • 120     PROQINASE GMBH
      • 121     QGEL SA
      • 122     QUIDEL
      • 123     RAYBIOTECH
      • 124     REACH BIO RESEARCH LABS
      • 125     READYCELL
      • 126     RETROGENIX U.K.
      • 127     ROCHE HOLDING AG
      • 128     ROCKLAND IMMUNOCHEMICALS, INC.
      • 129     SARTORIUS AG
      • 130     S-BIO
      • 131     SELEXIS SA-JSR LIFE SCIENCES
      • 132     SHENANDOAH BIOTECHNOLOGY INC.
      • 133     SRU BIOSYSTEMS, INC.
      • 134     STEM CELL TECHNOLOGIES
      • 135     STRESSMARQ BIOSCIENCES
      • 136     SURMODICS, INC.
      • 137     SYMANSIS
      • 138     SYSTEM BIOSCIENCES INC.
      • 139     TECAN GROUP
      • 140     THERMO FISHER SCIENTIFIC, INC.
      • 141     TISSUSE GMBH
      • 142     TREVIGEN (BIO-TECHNE)
      • 143     TTP LABTECH LTD
      • 144     VITL LIFE SCIENCE SOLUTIONS
      • 145     VIVOPHARM
      • 146     WUXI BIOLOGICS
      • 147     XENO DIAGNOSTICS
      • 148     YOKOGAWA ELECTRIC CORPORATION
      • 149     ZENBIO